This compound is a pharmaceutical reference standard intermediate, characterized as a pyridine-carboxamide derivative bearing chloro, trifluoromethyl, and ether-linked aromatic substructures. It is used in analytical and manufacturing quality control processes within the pharmaceutical supply chain.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1431697-81-2
Sorafenib
n.a
Sorafenib tosylate
active pharmaceutical ingredient
1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride
Pharmaceutical intermediate for synthesis
(3R,5R)-3-Amino-5-hydroxy-piperidine-1-carboxylic acid tert-butyl ester
Pharmaceutical intermediate
5-bromo-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-1H-Indole
Pharmaceutical intermediate for APIs
Fmoc-D-Aph(tBuCbm)-OH
Pharmaceutical intermediate for peptide synthesis
Regorafenib
active pharmaceutical ingredient
Regorafenib monohydrate
active pharmaceutical ingredient
4-[4-[[2-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
JWAKXXCHFJSKRN-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC=CC(=C3Cl)C(F)(F)F